Assessment of coronary artery disease based on coronary flow velocity reserve by transthoracic Doppler echocardiography and coronary computed tomography angiography in a patient with dextrocardia: a case report
- 143 Downloads
Compliance with ethical standards
Conflict of interest
Kentaro Kakuta received lecture fees from MSD K.K. Kaoru Dohi received lecture fees from AstraZeneca K.K., Astellas Pharma Inc., Abbott Japan Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Kowa Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., Fukuda Denshi Co., Ltd., Bristol-Myers Squibb, and Taisho Toyama Pharmaceutical Co., Ltd. Naoki Fujimoto received lecture from Eisai Co., Ltd. Takashi Yamanaka has no conflict of interest. Masaki Kawamura received lecture fees from Daiichi Sankyo Co., Ltd. Masaaki Ito received lecture fees from Pfizer Japan Inc., Daiichi Sankyo Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co., Ltd., Kowa Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Otsuka Pharmaceutical Co., Ltd., Actelion Pharmaceuticals Japan Ltd., Bristol-Myers Squibb, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Nippon Shinyaku Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Toa Eiyo Ltd. and Cook Japan, and received a research funding from Otsuka Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Bristol-Myers Squibb, Asahi Kasei Medical Co., Ltd., Shionogi & Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Ono Pharmaceutical Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Daiichi Sankyo Company Limited, Torii Pharmaceutical Co., Ltd., and Mitsubishi Tanabe Pharma Corporation. The companies associated with this funding were not involved in the preparation of the manuscript or the decision to publish the present case report.
Human rights statements and informed consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revisions. The patient gave written informed consent for publication.
- 1.Elbasheer E, Habib A, Salam A. Primary angioplasty and later elective multivessel stenting in a patient with dextrocardia: a case report and literature review. J Invasive Cardiol. 2010;22:125–8.Google Scholar
- 3.Watanabe H, Hozumi T, Hirata K, et al. Noninvasive coronary flow velocity reserve measurement in the posterior descending coronary artery for detecting coronary stenosis in the right coronary artery using contrast-enhanced transthoracic Doppler echocardiography. Echocardiography. 2004;21:225–33.CrossRefPubMedGoogle Scholar
- 4.Nakanishi H, Hirata K, Tsujioka H, et al. Incremental value of coronary flow velocity reserve, measured by transthoracic echocardiography, compared with computed tomography angiography alone, for detecting flow-limiting coronary stenoses. J Am Soc Echocardiogr. 2014;27:1230–7.CrossRefPubMedGoogle Scholar